Filing Details
- Accession Number:
- 0001645627-17-000111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-25 21:16:26
- Reporting Period:
- 2017-08-23
- Accepted Time:
- 2017-08-25 20:16:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,647,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,640,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 10,000 | $0.02 | 22,650,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,653,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,658,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,663,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,668,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,671,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,674,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,679,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,682,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,687,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,692,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,697,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 1,000 | $0.02 | 22,698,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,703,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,708,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,711,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.02 | 22,716,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,719,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,722,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 3,000 | $0.02 | 22,725,889 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
